PASG vs MSFT: Which Stock is Better?
Side-by-side comparison of Passage Bio Inc and Microsoft Corp in 2026
PASG
Passage Bio Inc
$11.67
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | PASG | MSFT | Winner |
|---|---|---|---|
| Market Cap | $37.44M | N/A | PASG |
| P/E Ratio | N/A | 26.31 | MSFT |
| EPS (TTM) | $N/A | $16.07 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze PASG
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PASG or MSFT a better investment?
Comparing PASG and MSFT: Passage Bio Inc has a market cap of $37.44M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PASG and MSFT?
PASG (Passage Bio Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PASG or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PASG or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for PASG.
Which company is more profitable: PASG or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for PASG.
Which is the larger company: PASG or MSFT?
Passage Bio Inc (PASG) is larger with a market cap of $37.44M compared to N/A for MSFT.
Should I buy PASG or MSFT in 2026?
Both PASG and MSFT have investment merit. PASG trades at $11.67 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PASG and MSFT stock?
Key differences: Market Cap ($37.44M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).